Genome wide expression profiling identifies genes associated with colorectal liver metastasis

Oncology Reports

Volumn 17, Issue 6, 2007, Pages 1541-1549

  Lin, H M ^a   Chatterjee, A ^a   Lin, Y H ^a   Anjomshoaa, A ^a   Fukuzawa, R ^a   McCall, J L ^b   Reeve, Anthony E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Colorectal cancer; Gene expression; Metastasis; Microarray

Indexed keywords

TUMOR MARKER;

ARTICLE; CELL PROLIFERATION; COLORECTAL TUMOR; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOME; HUMAN; LIVER TUMOR; METASTASIS; METHODOLOGY; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; TUMOR GENE; UPREGULATION;

CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENOME, HUMAN; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE PHOSPHORYLATION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 34548045560     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.17.6.1541     Document Type: Article

References (38)

1. Adam R and Vinet E: Regional treatment of metastasis: Surgery of colorectal liver metastases. Ann Oncol 15 (Suppl 4): 103-106, 2004.
2. Shih W, Chetty R and Tsao MS: Expression profiling by microarrays in colorectal cancer (Review). Oncol Rep 13: 517-524, 2005.
3. Friederichs J, Rosenberg R, Mages J, Janssen KP, Maeckl C, Nekarda H, Holzmann B and Siewert JR: Gene expression profiles of different clinical stages of colorectal carcinoma: Toward a molecular genetic understanding of tumor progression. Int J Colorectal Dis 20: 391-402, 2005. (Pubitemid 41086415)
4. Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, Charafe-Jauffret E, Loriod B, Bachelart L, Montfort J, Victorero G, Viret F, Ollendorff V, Fert V, Giovaninni M, Delpero JR, Nguyen C, Viens P, Monges G, Birnbaum D and Houlgatte R: Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 23: 1377-1391, 2004. (Pubitemid 38406833)
5. Li MH, Lin YM, Hasegawa S, Shimokawa T, Murata K, Kameyama M, Ishikawa O, Katagiri T, Tsunoda T, Nakamura Y and Furukawa Y: Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24: 305-312, 2004.
6. Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, Simmang C, Fleming J, Tavana D, Frenkel E and Becerra C: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9: 931-946, 2003. (Pubitemid 36323695)
7. Yanagawa R, Furukawa Y, Tsunoda T, Kitahara O, Kameyama M, Murata K, Ishikawa O and Nakamura Y: Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia 3: 395-401, 2001. (Pubitemid 32988809)
8. D'Arrigo A, Belluco C, Ambrosi A, Digito M, Esposito G, Bertola A, Fabris M, Nofrate V, Mammano E, Leon A, Nitti D and Lise M: Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer 115: 256-262, 2005. (Pubitemid 40586734)
9. Colantuoni C, Henry G, Zeger S and Pevsner J: SNOMAD (standardization and normalization of microarray data): Web-accessible gene expression data analysis. Bioinformatics 18: 1540-1541, 2002. (Pubitemid 35414548)
10. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta c(t)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
11. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179, 2004.
12. Chuaqui RF, Bonner RF, Best CJ, Gillespie JW, Flaig MJ, Hewitt SM, Phillips JL, Krizman DB, Tangrea MA, Ahram M, Linehan WM, Knezevic V and Emmert-Buck MR: Post-analysis follow-up and validation of microarray experiments. Nat Genet 32 (Suppl): 509-514, 2002. (Pubitemid 35435154)
13. Kothapalli R, Yoder SJ, Mane S and Loughran TP Jr: Microarray results: How accurate are they? BMC Bioinformatics 3: 22, 2002.
14. Liotta LA and Kohn EC: The microenvironment of the tumour-host interface. Nature 411: 375-379, 2001.
15. Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 432: 332-337, 2004. (Pubitemid 39551661)
16. Mueller MM and Fusenig NE: Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849, 2004. (Pubitemid 39472951)
17. Brower V: Feeding the flame: New research adds to role of inflammation in cancer development. J Natl Cancer Inst 97: 251-253, 2005.
18. Kinsella MG, Bressler SL and Wight TN: The regulated synthesis of versican, decorin, and biglycan: Extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 14: 203-234, 2004. (Pubitemid 38931846)
19. Gulubova MV: Collagen type iv, laminin, alpha-smooth muscle actin (alphasma), alpha1 and alpha6 integrins expression in the liver with metastases from malignant gastrointestinal tumours. Clin Exp Metastasis 21: 485-494, 2004.
20. Kalluri R: Basement membranes: Structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3: 422-433, 2003.
21. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y, Wu Y, Kerbel RS and Yang BB: Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18: 754-756, 2004.
22. Cattaruzza S, Schiappacassi M, Kimata K, Colombatti A and Perris R: The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells. FASEB J 18: 779-781, 2004.
23. Theocharis AD: Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim Biophys Acta 1588: 165-172, 2002.
24. Irby RB, McCarthy SM and Yeatman TJ: Osteopontin regulates multiple functions contributing to human colon cancer development and progression. Clin Exp Metastasis 21: 515-523, 2004.
25. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF and Yeatman TJ: Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 10: 184-190, 2004. (Pubitemid 38114178)
26. Wai PY, Mi Z, Guo H, Sarraf-Yazdi S, Gao C, Wei J, Marroquin CE, Clary B and Kuo PC: Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo ct26 murine colon adenocarinoma metastasis. Carcinogenesis 26: 741-751, 2005. (Pubitemid 41214336)
27. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe ML, Verscharen C, Rodriguez-Mazaneque JC, Zimmermann DR, Lemire JM, Fischer JW, Wight TN and Clowes AW: Versican v1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276: 13372-13378, 2001.
28. Bauvois B: Transmembrane proteases in cell growth and invasion: New contributors to angiogenesis? Oncogene 23: 317-329, 2004.
29. Blanchot-Jossic F, Jarry A, Masson D, Bach-Ngohou K, Paineau J, Denis MG, Laboisse CL and Mosnier JF: Up-regulated expression of ADAM17 in human colon carcinoma: Coexpression with EGFR in neoplastic and endothelial cells. J Pathol 207: 156-163, 2005. (Pubitemid 41404146)
30. de Visser KE, Eichten A and Coussens LM: Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6: 24-37, 2006. (Pubitemid 43053650)
31. Brand S, Dambacher J, Beigel F, Olszak T, Diebold J, Otte JM, Goke B and Eichhorst ST: CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310: 117-130, 2005. (Pubitemid 41393693)
32. Salcedo R and Oppenheim JJ: Role of chemokines in angiogenesis: CXCL12/sdf-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 10: 359-370, 2003. (Pubitemid 39004262)
33. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL and Weinberg RA: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348, 2005. (Pubitemid 40692295)
34. Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, Foshag L, Bilchik AJ and Hoon DS: Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 23: 2744-2753, 2005. (Pubitemid 46179464)
35. Zeelenberg IS, Ruuls-Van Stalle L and Roos E: The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 63: 3833-3839, 2003. (Pubitemid 36793074)
36. Seong J, Cho JH, Yang WI, Chung EJ and Kim NK: Apoptosis and proliferation in paired primary colorectal adenocarcinomas and their liver metastases. Yonsei Med J 45: 187-192, 2004. (Pubitemid 38660552)
37. Agui T, McConkey DJ and Tanigawa N: Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas. Anticancer Res 22: 1769-1776, 2002. (Pubitemid 34839194)
38. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH and Van Etten RA: Essential role for the peroxiredoxin PRDX1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565, 2003. (Pubitemid 36975778)